VIVORYON THERAPEUTICS NV (VVY.AS) Forecast, Price Target & Analyst Ratings

AMS:VVY • NL00150002Q7

Current stock price

1.33 EUR
+0.01 (+0.76%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIVORYON THERAPEUTICS NV (VVY.AS).

Forecast Snapshot

Consensus Price Target

Price Target
€5.95
+ 347.37% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 27, 2026
Period
Q4 / 2025
EPS Estimate
-€0.19
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€5.95
Upside
+ 347.37%
From current price of €1.33 to mean target of €5.95, Based on 7 analyst forecasts
Low
€5.05
Median
€5.10
High
€7.88

Price Target Revisions

1 Month
0.00%
3 Months
20.69%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for VVY.AS. The average price target is 5.95 EUR. This implies a price increase of 347.37% is expected in the next year compared to the current price of 1.33.
The average price target has been revised upward by 20.69% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

VVY Current Analyst RatingVVY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

VVY Historical Analyst RatingsVVY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
85.71%
VVY.AS was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about VVY.AS.
In the previous month the buy percentage consensus was at a similar level.
VVY.AS was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-06-06HAUCK AUFHAEUSER INVESTMENT BANKINGMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 27, 2026
Period
Q4 / 2025
EPS Estimate
-€0.19
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
28.93%
Number of Analysts
2

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

VVY.AS is expected to report earnings on 4/27/2026. The consensus EPS estimate for the next earnings is -0.19 EUR and the consensus revenue estimate is 0 EUR.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
VVY.AS revenue by date.VVY.AS revenue by date.
10.764M
-100.00%		-3.62M
100.00%		1.43B1.748B
22.24%
EBITDA
YoY % growth
VVY.AS ebitda by date.VVY.AS ebitda by date.
-12.633M
20.37%		-28.952M
-129.18%		-28.67M
0.97%		-21.516M
27.40%		-10.945M
47.42%		-14.076M
-28.61%		-16.904M
-20.09%		N/AN/AN/A
EBIT
YoY % growth
VVY.AS ebit by date.VVY.AS ebit by date.
-12.798M
20.07%		-29.113M
-127.48%		-28.837M
0.95%		-23.132M
27.31%		-10.911M
47.94%		-14.042M
-28.69%		-16.938M
-20.62%		-23.7M
-39.92%		1.404B
6,024.13%		1.721B
22.58%
Operating Margin
VVY.AS operating margin by date.VVY.AS operating margin by date.
-118.90%N/A796.60%N/AN/AN/AN/AN/A98.18%98.46%
EPS
YoY % growth
VVY.AS eps by date.VVY.AS eps by date.
-0.63
24.10%		-1.28
-103.17%		-1.12
12.50%		-0.94
29.46%		-0.39
50.14%		-0.45
-14.10%		-0.56
-24.72%		-1.07
-90.45%		40.77
3,919.15%		50.00
22.62%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q2 / 26 Q4 / 26 Q2 / 27 Q4 / 27
EPS
Q2Q % growth		-0.19
28.93%		-0.18
13.43%		-0.30
-57.89%		-0.18-0.30
Revenue
Q2Q % growth		N/AN/A
EBITDA
Q2Q % growth		-5.252M
25.08%		-5.353M
1.78%		-8.888M
-69.23%		N/AN/A
EBIT
Q2Q % growth		-5.353M
25.24%		-5.353M
3.08%		-8.989M
-67.92%		N/AN/A

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VVY.AS Yearly Revenue VS EstimatesVVY.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2021 2023 2029 2030 0 500M 1B 1.5B
VVY.AS Yearly EPS VS EstimatesVVY.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 10 20 30 40

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
8.87%
EPS Next 5 Year
121.74%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
8.27%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

VIVORYON THERAPEUTICS NV / VVY.AS Forecast FAQ

What is the average price target for VIVORYON THERAPEUTICS NV (VVY.AS) stock?

7 analysts have analysed VVY.AS and the average price target is 5.95 EUR. This implies a price increase of 347.37% is expected in the next year compared to the current price of 1.33.

When does VIVORYON THERAPEUTICS NV (VVY.AS) report earnings?

VIVORYON THERAPEUTICS NV (VVY.AS) will report earnings on 2026-04-27, after the market close.

What are the consensus estimates for VVY stock next earnings?

The consensus EPS estimate for the next earnings of VIVORYON THERAPEUTICS NV (VVY.AS) is -0.19 EUR and the consensus revenue estimate is 0 EUR.